We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
+10.08%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$2.71M
(-2.2%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-10.18%
Top 10 Holdings %
Top 10 Hldgs %
66.14%
Holding
517
New
1
Increased
22
Reduced
44
Closed
435
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$2.5M |
| 2 |
AT&T
T
|
+$1.11M |
| 3 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$523K |
| 4 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$505K |
| 5 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$320K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$910K |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$823K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$714K |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$695K |
| 5 |
Pfizer
PFE
|
+$671K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.33% |
| 2 | Consumer Staples | 6.59% |
| 3 | Energy | 5.79% |
| 4 | Technology | 5.35% |
| 5 | Financials | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$127B
| $47.9M | 39.45% |
772,467
-11,612
| -1% | -$714K |
|
2
Gilead Sciences
GILD
$161B
| $7.39M | 6.09% |
126,855
-1,863
| -1% | -$112K |
|
|
3
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $6.7M | 5.52% |
227,276
-25,975
| -10% | -$695K |
|
|
4
Intel
INTC
$466B
| $4.09M | 3.37% |
82,026
+51,097
| +165% | +$2.5M |
|
|
5
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $3.45M | 2.84% |
182,180
-47,774
| -21% | -$823K |
|
6
CVS Health
CVS
$137B
| $2.67M | 2.2% |
39,150
-5,360
| -12% | -$349K |
|
|
7
Pfizer
PFE
$140B
| $2.32M | 1.91% |
62,986
-18,305
| -23% | -$671K |
|
8
Kraft Heinz
KHC
$30.4B
| $2.06M | 1.7% |
59,422
-5,595
| -9% | -$182K |
|
9
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
| $1.88M | 1.55% |
31,310
+3,533
| +13% | +$212K |
|
10
Home Depot
HD
$332B
| $1.85M | 1.53% |
6,985
-67
| -1% | -$18.4K |
|
11
ExxonMobil
XOM
$651B
| $1.78M | 1.47% |
43,182
+778
| +2% | +$29.2K |
|
12
AB InBev
BUD
$158B
| $1.74M | 1.43% |
24,891
-6,439
| -21% | -$407K |
|
13
Amazon
AMZN
$2.5T
| $1.57M | 1.29% |
9,620
| – | – |
|
14
Apple
AAPL
$4.89T
| $1.41M | 1.16% |
10,591
-194
| -2% | -$23.3K |
|
15
First Trust Managed Municipal ETF
FMB
$2.03B
| $1.38M | 1.14% |
24,400
+4,000
| +20% | +$224K |
|
|
16
AT&T
T
$165B
| $1.37M | 1.13% |
63,253
+51,375
| +433% | +$1.11M |
|
17
Enterprise Products Partners
EPD
$83.8B
| $1.15M | 0.95% |
58,722
-2,528
| -4% | -$47.1K |
|
18
Altria Group
MO
$122B
| $1.15M | 0.94% |
27,921
+2,702
| +11% | +$108K |
|
19
Aflac
AFL
$63.9B
| $1.14M | 0.94% |
25,585
-400
| -2% | -$16.4K |
|
|
PARA
20
DELISTED
Paramount Global Class B
PARA
| $1.11M | 0.92% |
29,907
-1,789
| -6% | -$57.4K |
|
21
SLB Ltd
SLB
$77.8B
| $1.09M | 0.9% |
49,961
+5,561
| +13% | +$105K |
|
|
CHL
22
DELISTED
China Mobile Limited
CHL
| $967K | 0.8% |
33,886
+4,286
| +14% | +$132K |
|
23
Raymond James Financial
RJF
$32.5B
| $947K | 0.78% |
14,850
| – | – |
|
24
Philip Morris
PM
$301B
| $919K | 0.76% |
11,100
-807
| -7% | -$62.8K |
|
25
BP
BP
$113B
| $898K | 0.74% |
43,761
+2,761
| +7% | +$52K |
|
Similar funds
VPW
EGP
FA
LP
WWMP
HCM
FCU
OCA
Chiron Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Chiron Capital Management held 517 positions worth $121M, down 2.2% from $124M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Chiron Capital Management withdrew a net $12.4M in Q4 2020, closing 435 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $312K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Consumer Staples and Energy.
Against the trend, Chiron Capital Management opened a new position in Viatris worth $312K.
- Chiron Capital Management's largest Q4 2020 buy was Viatris: 16,662 shares worth $312K.
- Chiron Capital Management added most to Intel in Q4 2020, an estimated $2.5M increase.
- Chiron Capital Management's biggest Q4 2020 reduction was Capital One, cutting an estimated $910K.
- Chiron Capital Management fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $312K.
- Chiron Capital Management's ten largest holdings make up 66% of its $121M portfolio in Q4 2020.
- Chiron Capital Management opened 1 new position and closed 435 in Q4 2020.
- Chiron Capital Management's portfolio value fell 2.2% quarter-over-quarter to $121M.
Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.